We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

Hutchison China MediTech

Impressive data means SANET-ep trial stopped early

Lighthouse | 14 June 2019


Vulpes investment brings £3.88m in new funds

Lighthouse | 13 June 2019


ASCO: more supportive data for bemcentinib

Update | 05 June 2019

Mereo BioPharma

Encouraging interim BPS-804 data in OI

Update | 31 May 2019

Hutchison China MediTech

Timing is right for a Hong Kong debut

Update | 30 May 2019


Getting back on the front foot

Update | 21 May 2019


SCIB2 to use new nanoparticle formulation

Lighthouse | 20 May 2019

Mereo BioPharma

Focus shifts back to imminent data

Update | 08 May 2019


Dosing advances to second cohort in CARMA Phase I

Lighthouse | 08 May 2019


Building momentum

Update | 07 May 2019
1 2 3 4 5 6 7 8 9 10 11
110 results found.